Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2016 (2016), Article ID 8540904, 6 pages
http://dx.doi.org/10.1155/2016/8540904
Research Article

Audit of Helicobacter pylori Testing in Microbiology Laboratories in England: To Inform Compliance with NICE Guidance and the Feasibility of Routine Antimicrobial Resistance Surveillance

1Primary Care Unit, Public Health England, Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK
2Histology Department, Cheltenham General Hospital, Sandford Rd., Cheltenham, Gloucestershire GL53 7AN, UK
32gether NHS Foundation Trust, Rikenel, Montpellier, Gloucester GL1 1LY, UK
4Bacteriology Reference Department, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK

Received 8 September 2016; Accepted 26 September 2016

Academic Editor: Todd R. Callaway

Copyright © 2016 Rosalie Allison et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Gisbert and X. Calvet, “Helicobacter pylori ‘test-and-treat’ strategy for management of dyspepsia: a comprehensive review,” Clinical and Translational Gastroenterology, vol. 4,, no. 3 article e32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. National Institute for Health and Care Excellence (NICE), Gastro-Oesophageal Reflux Disease and Dyspepsia in Adults: Investigation and Management, 2014, https://www.nice.org.uk/guidance/cg184/chapter/1-Recommendations#helicobacter-pylori-testing-and-eradication.
  3. A. Goel and R. Aggarwal, “Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection,” Cochrane Database of Systematic Reviews, no. 10, Article ID CD010776, 2013. View at Publisher · View at Google Scholar
  4. A. C. Marín, A. G. McNicholl, V. Savarino et al., “Optimum second-line regimens for Helicobacter pylori eradication,” Cochrane Database of Systematic Reviews, no. 10, Article ID CD011363, 2014. View at Publisher · View at Google Scholar
  5. T. Aebischer, T. F. Meyer, and L. P. Andersen, “Inflammation, immunity, and vaccines for helicobacter,” Helicobacter, vol. 15, no. 1, pp. 21–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Talley, “Dyspepsia: how to manage and how to treat?” Alimentary Pharmacology & Therapeutics, vol. 16, no. 4, pp. 95–104, 2002. View at Google Scholar
  7. F. Mégraud, “H pylori antibiotic resistance: prevalence, importance, and advances in testing,” Gut, vol. 53, no. 9, pp. 1374–1384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. H. Hunt, S. D. Xiao, F. Megraud et al., “Helicobacter pylori in developing countries. World Gastroenterology Organisation global guideline,” Journal of Gastrointestinal and Liver Diseases, vol. 20, no. 3, pp. 299–304, 2011. View at Google Scholar · View at Scopus
  9. Q. Ren, X. Yan, Y. Zhou, and W. X. Li, “Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection,” The Cochrane Database of Systematic Reviews, no. 2, Article ID CD009477, 2011. View at Publisher · View at Google Scholar
  10. BC Guidelines, “Dyspepsia with or without Helicobacter pylori infection-Clinical Approach in Adults,” 2009
  11. K. E. L. McColl, “Helicobacter pylori infection,” The New England Journal of Medicine, vol. 362, no. 17, pp. 1597–1604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Gisbert and J. M. Pajares, “Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review,” Helicobacter, vol. 9, no. 4, pp. 347–368, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Nocon, A. Kuhlmann, A. Leodolter et al., “Efficacy and cost-effectiveness of the 13C-urea breath test as the primary diagnostic investigation for the detection of Helicobacter pylori infection compared to invasive and non-invasive diagnostic tests,” GMS Health Technology Assessment, vol. 5, 2009. View at Publisher · View at Google Scholar
  14. P. Malfertheiner, F. Megraud, C. A. O'Morain et al., “Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report,” Gut, vol. 61, no. 5, pp. 646–664, 2012. View at Publisher · View at Google Scholar
  15. A. Federico, A. G. Gravina, A. Miranda, C. Loguercio, and M. Romano, “Eradication of Helicobacter pylori infection: which regimen first?” World Journal of Gastroenterology, vol. 20, no. 3, pp. 665–672, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. A. M. McNulty, G. Lasseter, I. Shaw et al., “Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?” Alimentary Pharmacology and Therapeutics, vol. 35, no. 10, pp. 1221–1230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Yaxley and B. Chakravarty, “Helicobacter pylori eradication—an update on the latest therapies,” Australian Family Physician, vol. 43, no. 5, pp. 301–305, 2014. View at Google Scholar · View at Scopus
  18. A. Talebi Bezmin Abadi, “Therapy of Helicobacter pylori: present medley and future prospective,” BioMed Research International, vol. 2014, Article ID 124607, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Testerman and J. Morris, “Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment,” World Journal of Gastroenterology, vol. 20, no. 36, pp. 12781–12808, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Wannmacher, Review of the Evidence for H. Pylori Treatment Regimens, 18th Expert Committee on the Selection and Use of Essential Medicines, 2011.
  21. S. A. Chisholm, E. L. Teare, K. Davies, and R. J. Owen, “Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000–2005),” Euro Surveillance, vol. 12, no. 7, pp. E3–E4, 2007. View at Google Scholar · View at Scopus
  22. N. Wüppenhorst, S. Draeger, H. P. E. Stüger et al., “Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany,” The Journal of Antimicrobial Chemotherapy, vol. 69, no. 11, pp. 3127–3133, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Cambau, V. Allerheiligen, C. Coulon et al., “Evaluation of a new test, GenoType HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori,” Journal of Clinical Microbiology, vol. 47, no. 11, pp. 3600–3607, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Lottspeich, A. Schwarzer, K. Panthel, S. Koletzko, and H. Rüssmann, “Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children,” Journal of Clinical Microbiology, vol. 45, no. 6, pp. 1718–1722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Makristathis and A. M. Hirschl, “Detection and clarithromycin susceptibility testing of Helicobacter pylori in stool specimens by real-time PCR: how to get accurate test results,” Journal of Clinical Microbiology, vol. 45, no. 8, p. 2756, 2007. View at Publisher · View at Google Scholar · View at Scopus